A comprehensive account of the whistleblowers’ side of a scandal that rocked the most hallowed halls in science. This still-unfolding saga is a cautionary tale about corruption, hype, and power that raises profound questions about how to uphold integrity in scientific research

Quick Read

On Monday, the Food and Drug Administration announced plans to crack down on so-called “homeopathic remedies”—treatments that due to agency enforcement policy have managed to avoid regulatory oversight

Quick Read

The scale of “fake research” in the UK appears to have been underestimated, a BBC investigation suggests

Quick Read

Shawn Blazsek knew a string of concussions from high school football and boxing was catching up with him. He would go days without sleeping and was forgetting how to tie his shoes. Still, at age 33, he was stunned after being told he had Alzheimer’s disease

Quick Read

Now they’re crying foul. t had a catchy name, an irresistible backstory, and plenty of Silicon Valley buzz. So it was no surprise that “Scout,” a device marketed as a real-life version of the “Star Trek” tricorder, made history in 2013 when its manufacturer, the startup Scanadu, raised a record $1.5 million on the crowdfunding website Indiegogo in a matter of weeks to bring it to consumers

Quick Read

Neuroskeptic asks: Is it the job of peer reviewers to detect scientific fraud? He’s been pondering this question for a while but lately, interest was sparked by the case of a retracted cancer biology paper in the high-profile journal Nature Cell Biology

Quick Read

The Stress Test

February 22, 2016

Rivalries, intrigue, and fraud in the world of stem-cell research

Quick Read

Most hiring committees and tenure review boards in the social sciences continue to give more weight to publications or the potential to publish in top technical journals above other factors when making decisions that affect the careers of young academics. But popular media attention increasingly works in a candidate’s favor as well. For tenure decisions

Quick Read